Gear Up With Summer-Ready Watches Built For Everyday Toughness

Gear up for summer with watches that are built for everyday toughness. These timepieces are designed to withstand the elements and keep up with an active lifestyle.

Concentrix Strengthens Employee Security And Well-Being Through Comprehensive Benefits

Concentrix is dedicated to enhancing employee security and well-being through a wide range of comprehensive benefits.

Vivant Water 20 MLD Desalination Plant Partners With MCWD For Water Supply In Metro Cebu

Vivant Water has entered into a significant partnership with the Metropolitan Cebu Water District to secure water supply for Metro Cebu.

Balik Probinsya Tips: 4 Ways To Maximize Your Out Of Town Trip

Summer is here, and many are heading to their hometowns for family reunions or a much-needed break. Here are ways to enhance the experience.

Sec. Dela Peña: DOST To Look For More Participants In VCO Clinical Trial

Gagana kaya ang VCO upang mapagaling ang mga taong may COVID-19?

Sec. Dela Peña: DOST To Look For More Participants In VCO Clinical Trial

15
15

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The Department of Science and Technology (DOST) will look for more participants in the community-based study on the effectiveness of virgin coconut oil (VCO) in treating coronavirus disease (Covid-19) patients, which it has been conducting at the Santa Rosa Community Hospital in Laguna.

During the “Laging Handa” public briefing, Secretary Fortunato dela Peña said most of the participants in this study―with mild cases of Covid-19―were already sent home.

He, however, did not specify how many recovered and the total number of participants in this study.

“We want to add the number of participants. For 28 days, VCO will be included in their three meals,” he said during the briefing.

Dela Peña earlier said the target number of participants is 90.

On Tuesday, he said half of them would be provided with VCO, to compare the performance with the other 45 persons who would not be given the VCO.

Participants should give their consent, and those who will be provided with VCO should be those without a high cholesterol level, he added.

The DOST also planned to do a hospital-based clinical trial to assess the possible benefits of VCO if given to patients with moderate to severe Covid-19.

This has not started yet, and will be done at the Philippine General Hospital, dela Peña said.

He earlier said VCO has antiviral properties and has no harmful effects and toxicity. (PNA)